Effective gene–virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5
Open Access
- 30 April 2005
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (4) , 531-541
- https://doi.org/10.1016/j.ymthe.2004.12.003
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Oncolytic Activity of p53-Expressing Conditionally Replicative Adenovirus AdΔ24-p53 against Human Malignant GliomaCancer Research, 2004
- A Tumor-Targeted and Conditionally Replicating Oncolytic Adenovirus Vector Expressing TRAIL for Treatment of Liver MetastasesMolecular Therapy, 2004
- Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNγ-induced apoptosisGene Therapy, 2003
- Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene-Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian CancerJournal of Clinical Oncology, 2002
- Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived FactorJournal of Biological Chemistry, 2002
- E1B-Deleted Adenovirus (dl1520) Gene Therapy for Patients with Primary and Secondary Liver TumorsHuman Gene Therapy, 2001
- Effective Gene Therapy for Pancreatic Cancer by Cytokines Mediated by Restricted Replication-Competent AdenovirusHuman Gene Therapy, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Newcastle Disease Virus as an Antineoplastic Agent: Induction of Tumor Necrosis Factor- and Augmentation of Its Cytotoxicity2JNCI Journal of the National Cancer Institute, 1988